Robert A. Anders
Impact in
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 89
- Cancer Immunotherapy and Biomarkers 60
- Pancreatic and Hepatic Oncology Research 19
- Hepatology 29
- Hepatocellular Carcinoma Treatment and Prognosis 23
- Co-authors
- Janis Marie Taube (33 shared papers)Drew M. Pardoll (22 shared papers)Suzanne Louise Topalian (13 shared papers)Lieping Chen (8 shared papers)Haiying Xu (16 shared papers)Alison Patricia Klein (5 shared papers)Julie Renee Brahmer (4 shared papers)Duojia Pan (8 shared papers)
- Journals
- Clinical Cancer Research (16 papers)Cancer Immunology Research (12 papers)Journal for ImmunoTherapy of Cancer (11 papers)The American Journal of Surgical Pathology (9 papers)Journal of Clinical Investigation (9 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Robert A. Anders
287 papers receiving 59.4k citations
Robert A. Anders's Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 23.9k
- Hepatology 2.3k
- Cell Biology 2.5k
- Immunology 2.8k
- Cancer Research 1.6k
Countries citing papers authored by Robert A. Anders
This map shows the geographic impact of Robert A. Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Anders more than expected).
Fields of papers citing papers by Robert A. Anders
This network shows the impact of papers produced by Robert A. Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Anders. The network helps show where Robert A. Anders may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Anders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 293 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer Hit paper breakdown → | 2012 | 10619 |
| 2 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency Hit paper breakdown → | 2015 | 7864 |
| 3 | Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Hit paper breakdown → | 2017 | 5323 |
| 4 | Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates Hit paper breakdown → | 2010 | 2594 |
| 5 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy Hit paper breakdown → | 2016 | 2265 |
| 6 | Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy Hit paper breakdown → | 2014 | 2067 |
| 7 | Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals Hit paper breakdown → | 2007 | 1971 |
| 8 | Fulminant Myocarditis with Combination Immune Checkpoint Blockade Hit paper breakdown → | 2016 | 1883 |
| 9 | Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape Hit paper breakdown → | 2012 | 1856 |
| 10 | The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints Hit paper breakdown → | 2014 | 1264 |
| 11 | Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria Hit paper breakdown → | 2018 | 902 |
| 12 | Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2021 | 728 |
| 13 | A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer Hit paper breakdown → | 2017 | 666 |
| 14 | The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals Hit paper breakdown → | 2010 | 660 |
| 15 | Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas Hit paper breakdown → | 2013 | 567 |
| 16 | Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade Hit paper breakdown → | 2019 | 503 |
| 17 | 2007 | 478 | |
| 18 | 2012 | 469 | |
| 19 | 2008 | 461 | |
| 20 | 2014 | 458 |
About Robert A. Anders
Robert A. Anders is a scholar working on Oncology, Hepatology, Surgery, Cell Biology and Immunology, having authored 293 papers that have together received 60.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (60 papers), Hepatocellular Carcinoma Treatment and Prognosis (23 papers), Pancreatic and Hepatic Oncology Research (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Pediatric Hepatobiliary Diseases and Treatments (12 papers), Hippo pathway signaling and YAP/TAZ (10 papers), T-cell and B-cell Immunology (6 papers) and Bariatric Surgery and Outcomes (6 papers). The work is most often cited by research in Oncology (23.9k citations), Hepatology (2.3k citations), Cell Biology (2.5k citations), Immunology (2.8k citations) and Cancer Research (1.6k citations). Robert A. Anders has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Janis Marie Taube, Drew M. Pardoll, Suzanne Louise Topalian, Lieping Chen, Haiying Xu, Alison Patricia Klein, Julie Renee Brahmer, Duojia Pan, Jixin Dong and Anirban Maitra. Their work appears in journals such as Clinical Cancer Research, Cancer Immunology Research, Journal for ImmunoTherapy of Cancer, The American Journal of Surgical Pathology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.